Background The global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease （COPD） guidelines classify patients into four groups according to the number of symptoms and the l...Background The global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease （COPD） guidelines classify patients into four groups according to the number of symptoms and the level of future risk of acute exacerbation COPD （AECOPD）. This study aimed to compare the results of different methods used in diagnosis of COPD and evaluate the accuracy of the assessment methods in guiding clinical practice. Methods A survey was conducted of 194 COPD outpatients between March and September 2012. Demographic characteristics, the number of exacerbations the patient has had within the previous 12 months, COPD assessment test （CAT）, Modified British Medical Research Council （mMRC） scale, and results of the lung function tests were recorded. Results Of the 194 patients assessed, 21 had a CAT score 〉10 and an mMRC grade ≤1, 13 had a CAT score 〈10 and an mMRC grade ≥2. A predicted forced expiratory volume in one second （FEV1%） of 〈50% with less than two acute exacerbations was observed in 39 patients, while a predicted FEV1% of 〉50% was noted in 20 patients with two or more acute exacerbations. The sensitivity of a predicted FEV1% 〈50% in predicting the risk of AECOPD in the future was 80.9%, while that in the real number of AECOPD events recorded was 62.8%, the difference being statistically significant （P=0.004）. The sensitivity of CAT in predicting the severity of symptoms was 90%, while that of mMRC was 83.8%, and the difference was not statistically significant. Conclusions The COPD assessment method recommended by the global initiative for chronic obstructive pulmonary disease （GOLD） 2011 is complicated and should be simplified. CAT is more comprehensive and accurate than mMRC. The lung function classification is a better tool for predicting the risk of AECOPD in the future, and the number of AECOPD can be referred to when required.展开更多
通过研究益生菌Lactobacillus casei Zhang冻干粉对小鼠急性毒性作用,为该菌株的安全应用提供依据。连续14d对小鼠灌胃不同剂量的L.casei Zhang冻干粉,各剂量组小鼠的一般体征、肝脏功能、脏器指数以及肝、肾、脾形态学的观察结果与对...通过研究益生菌Lactobacillus casei Zhang冻干粉对小鼠急性毒性作用,为该菌株的安全应用提供依据。连续14d对小鼠灌胃不同剂量的L.casei Zhang冻干粉,各剂量组小鼠的一般体征、肝脏功能、脏器指数以及肝、肾、脾形态学的观察结果与对照组相比无显著差异(P>0.05)。急性毒性试验及相关指标检测结果显示L.casei Zhang冻干粉无毒副作用。展开更多
为实现L. casei Zhang的高密度培养,在之前优化增殖培养基的基础上进一步寻求适宜该菌的培养条件。研究了不同中和剂、缓冲盐浓度、葡萄糖浓度、pH值控制、通气条件和补料分批培养对菌体在恒pH条件下发酵的影响,根据不同条件下菌体的比...为实现L. casei Zhang的高密度培养,在之前优化增殖培养基的基础上进一步寻求适宜该菌的培养条件。研究了不同中和剂、缓冲盐浓度、葡萄糖浓度、pH值控制、通气条件和补料分批培养对菌体在恒pH条件下发酵的影响,根据不同条件下菌体的比生长速率、菌体密度和活菌数情况,确定L. casei Zhang较适宜的高密度培养条件为:培养基葡萄糖浓度为80g/L～100g/L,以氨水为中和剂使pH保持5.9,采用间歇通氮气的方法保持环境厌氧,分批培养方式下37°C保温发酵10h～12h后,L. casei Zhang细胞干重达到7g/L,活菌数3.5×1010 CFU/mL,比优化前提高7倍以上,能够满足益生菌制品生产要求的高菌体密度。展开更多
文摘Background The global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease （COPD） guidelines classify patients into four groups according to the number of symptoms and the level of future risk of acute exacerbation COPD （AECOPD）. This study aimed to compare the results of different methods used in diagnosis of COPD and evaluate the accuracy of the assessment methods in guiding clinical practice. Methods A survey was conducted of 194 COPD outpatients between March and September 2012. Demographic characteristics, the number of exacerbations the patient has had within the previous 12 months, COPD assessment test （CAT）, Modified British Medical Research Council （mMRC） scale, and results of the lung function tests were recorded. Results Of the 194 patients assessed, 21 had a CAT score 〉10 and an mMRC grade ≤1, 13 had a CAT score 〈10 and an mMRC grade ≥2. A predicted forced expiratory volume in one second （FEV1%） of 〈50% with less than two acute exacerbations was observed in 39 patients, while a predicted FEV1% of 〉50% was noted in 20 patients with two or more acute exacerbations. The sensitivity of a predicted FEV1% 〈50% in predicting the risk of AECOPD in the future was 80.9%, while that in the real number of AECOPD events recorded was 62.8%, the difference being statistically significant （P=0.004）. The sensitivity of CAT in predicting the severity of symptoms was 90%, while that of mMRC was 83.8%, and the difference was not statistically significant. Conclusions The COPD assessment method recommended by the global initiative for chronic obstructive pulmonary disease （GOLD） 2011 is complicated and should be simplified. CAT is more comprehensive and accurate than mMRC. The lung function classification is a better tool for predicting the risk of AECOPD in the future, and the number of AECOPD can be referred to when required.
文摘通过研究益生菌Lactobacillus casei Zhang冻干粉对小鼠急性毒性作用,为该菌株的安全应用提供依据。连续14d对小鼠灌胃不同剂量的L.casei Zhang冻干粉,各剂量组小鼠的一般体征、肝脏功能、脏器指数以及肝、肾、脾形态学的观察结果与对照组相比无显著差异(P>0.05)。急性毒性试验及相关指标检测结果显示L.casei Zhang冻干粉无毒副作用。
文摘为实现L. casei Zhang的高密度培养,在之前优化增殖培养基的基础上进一步寻求适宜该菌的培养条件。研究了不同中和剂、缓冲盐浓度、葡萄糖浓度、pH值控制、通气条件和补料分批培养对菌体在恒pH条件下发酵的影响,根据不同条件下菌体的比生长速率、菌体密度和活菌数情况,确定L. casei Zhang较适宜的高密度培养条件为:培养基葡萄糖浓度为80g/L～100g/L,以氨水为中和剂使pH保持5.9,采用间歇通氮气的方法保持环境厌氧,分批培养方式下37°C保温发酵10h～12h后,L. casei Zhang细胞干重达到7g/L,活菌数3.5×1010 CFU/mL,比优化前提高7倍以上,能够满足益生菌制品生产要求的高菌体密度。
